ArticleFuture oncology (London, England)2025

Design and rationale of the phase II PANDORA trial: first line chemo-immunotherapy in advanced Merkel cell carcinoma.

Simone Oldani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.